Skip to main content
. 2022 May 27;14(5):956–971. doi: 10.4254/wjh.v14.i5.956

Figure 2.

Figure 2

UBE2C, UBE2T, and UBE2S expression levels in hepatocellular carcinoma based on normal and tumor sample types and based on cancer stages (the Cancer Genome Atlas database). A: Expression of UBE2C in hepatocellular carcinoma (HCC) based on sample types; B: Expression of UBE2T in HCC based on sample types; C: Expression of UBE2S in HCC based on sample types; D: Expression of UBE2C in HCC based on individual cancer stages; E: Expression of UBE2T in HCC based on individual cancer stages; F: Expression of UBE2S in HCC based on individual cancer stages (aP < 0.05; cP < 0.001).